Jennifer Mariano

Title: Jennifer Mariano: Innovator in Ubiquitin Ligase Research

Introduction

Jennifer Mariano is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of molecular biology, particularly in the study of ubiquitin ligases. Her work has implications for both diagnostic and therapeutic applications.

Latest Patents

Jennifer Mariano holds a patent for the invention titled "Ube2G2 binding domain in the ubiquitin ligase gp78 and methods of use thereof." This patent features isolated nucleic acid molecules, designated G2BD nucleic acid molecules, which encode the binding site from the gp78 ubiquitin ligase that binds to the Ube2G2 ubiquitin conjugating enzyme. The invention further provides isolated G2BD proteins and fusion proteins. Additionally, it includes diagnostic and therapeutic methods, as well as screening assays utilizing compositions of the invention. She has 1 patent to her name.

Career Highlights

Jennifer Mariano is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to engage in cutting-edge research and contribute to advancements in health sciences.

Collaborations

Throughout her career, Jennifer has collaborated with notable colleagues, including Allan M Weissman and Bo Chen. These collaborations have further enriched her research and expanded the impact of her work.

Conclusion

Jennifer Mariano is a dedicated inventor whose work in ubiquitin ligase research is paving the way for new diagnostic and therapeutic methods. Her contributions are vital to the ongoing advancements in molecular biology and health sciences.